Status: Not yet recruiting
High Versus Lower Intensity Surveillance Following Resection of Retroperitoneal Sarcoma
The SARveillance trial is an efficient, pragmatic, multi-centre, international, stratified, partially-randomised, patient-preference trial within a registry of high versus lower intensity radiological surveillance following primary resection of retroperitoneal, abdominal and pelvic soft tissue sarcoma. The trial design is stratified by sarcoma tumour grade (high/intermediate grade and low grade).
Participants needed: 584
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoUpdated: Oct 16, 2024Locations: 2
Eligibility criteria
Adult patients (greater than 18 years) [+4]
Metastatic disease at time of randomisation [+7]